AGENCIES, New Delhi: After the national capital conducted the country’s first successful plasma therapy, there has a been spike of rush to donate plasma for the treatment of coronavirus cases. But on Tuesday, the Union Ministry of Health and Family Welfare has said that plasma therapy is still in an experimental stage and can even prove “life threatening” for a patient.
At the regular news briefing, Health Ministry Joint Secretary Lav Agarwal said that as of today, there were no approved therapies for treatment of novel coronavirus, including plasma therapy.
“Plasma therapy for coronavirus is still in an experimental stage and can even prove ‘life threatening’ for a patient,” Agarwal said.
“The ICMR (Indian Council of Medical Research) is doing an experiment to identify and have additional understanding of this therapy. Till it is approved, no one should use it; it’ll be harmful to patient and illegal,” he added.
As of now, two studies on six and 10 patients, respectively, have shown encouraging results as far as treatment of COVID-19 patients using the plasma therapy is concerned.
“I think we need to look at it in a more research type of a treatment modality rather than which actually can be done for all patients suffering with COVID-19. We will have to select patients properly. Just taking plasma for everyone who has recovered and giving it to sick patients may not be enough. We have to do a detailed antibody titer testing to see what is the degree of antibodies in the plasma,” AIIMS Director Randeep Guleria told news agency ANI earlier.
Recently, singer Kanika Kapoor, who has been slammed and trolled by netizens and other celebrities for her irresponsible behaviour after she tested positive for coronavirus, is now receiving praise for her efforts as she decided to donate her plasma which might help other patients recover.
“In the last few days, we have tried plasma therapy on four patients at Lok Nayak Jai Prakash Narayan (LNJP) Hospital. Till now the results are encouraging,” Kejriwal said during a press conference.